359 related articles for article (PubMed ID: 9239410)
41. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
Goyenvalle A; Vulin A; Fougerousse F; Leturcq F; Kaplan JC; Garcia L; Danos O
Science; 2004 Dec; 306(5702):1796-9. PubMed ID: 15528407
[TBL] [Abstract][Full Text] [Related]
42. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.
Gaedigk R; Law DJ; Fitzgerald-Gustafson KM; McNulty SG; Nsumu NN; Modrcin AC; Rinaldi RJ; Pinson D; Fowler SC; Bilgen M; Burns J; Hauschka SD; White RA
Neuromuscul Disord; 2006 Mar; 16(3):192-203. PubMed ID: 16487708
[TBL] [Abstract][Full Text] [Related]
43. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero.
Bilbao R; Reay DP; Wu E; Zheng H; Biermann V; Kochanek S; Clemens PR
Gene Ther; 2005 Jan; 12(1):39-47. PubMed ID: 15483668
[TBL] [Abstract][Full Text] [Related]
44. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.
Ragot T; Vincent N; Chafey P; Vigne E; Gilgenkrantz H; Couton D; Cartaud J; Briand P; Kaplan JC; Perricaudet M
Nature; 1993 Feb; 361(6413):647-50. PubMed ID: 8437625
[TBL] [Abstract][Full Text] [Related]
45. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases.
Karpati G; Acsadi G
Muscle Nerve; 1993 Nov; 16(11):1141-53. PubMed ID: 8413366
[TBL] [Abstract][Full Text] [Related]
46. Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres.
Baranov A; Glazkov P; Kiselev A; Ostapenko O; Mikhailov V; Ivaschenko T; Sabetsky V; Baranov V
Gene Ther; 1999 Aug; 6(8):1406-14. PubMed ID: 10467365
[TBL] [Abstract][Full Text] [Related]
47. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement.
Kapsa R; Quigley A; Lynch GS; Steeper K; Kornberg AJ; Gregorevic P; Austin L; Byrne E
Hum Gene Ther; 2001 Apr; 12(6):629-42. PubMed ID: 11426463
[TBL] [Abstract][Full Text] [Related]
48. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
Smith J; Goldsmith C; Ward A; LeDieu R
Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
[TBL] [Abstract][Full Text] [Related]
49. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
[TBL] [Abstract][Full Text] [Related]
50. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
[TBL] [Abstract][Full Text] [Related]
51. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
[TBL] [Abstract][Full Text] [Related]
52. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
Xiong F; Xiao S; Yu M; Li W; Zheng H; Shang Y; Peng F; Zhao C; Zhou W; Chen H; Fang L; Chamberlain JS; Zhang C
BMC Neurosci; 2007 Jul; 8():50. PubMed ID: 17617925
[TBL] [Abstract][Full Text] [Related]
53. Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice.
Guibinga GH; Ebihara S; Nalbantoglu J; Holland P; Karpati G; Petrof BJ
Mol Ther; 2001 Nov; 4(5):499-507. PubMed ID: 11708887
[TBL] [Abstract][Full Text] [Related]
54. Progress toward gene therapy of Duchenne muscular dystrophy.
Hartigan-O'Connor D; Chamberlain JS
Semin Neurol; 1999; 19(3):323-32. PubMed ID: 12194388
[TBL] [Abstract][Full Text] [Related]
55. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
[TBL] [Abstract][Full Text] [Related]
56. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene.
Vincent N; Ragot T; Gilgenkrantz H; Couton D; Chafey P; Grégoire A; Briand P; Kaplan JC; Kahn A; Perricaudet M
Nat Genet; 1993 Oct; 5(2):130-4. PubMed ID: 8252038
[TBL] [Abstract][Full Text] [Related]
57. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs.
Acsadi G; Dickson G; Love DR; Jani A; Walsh FS; Gurusinghe A; Wolff JA; Davies KE
Nature; 1991 Aug; 352(6338):815-8. PubMed ID: 1881437
[TBL] [Abstract][Full Text] [Related]
58. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.
Roberts ML; Wells DJ; Graham IR; Fabb SA; Hill VJ; Duisit G; Yuasa K; Takeda S; Cosset FL; Dickson G
Hum Mol Genet; 2002 Jul; 11(15):1719-30. PubMed ID: 12095914
[TBL] [Abstract][Full Text] [Related]
59. Effective repetitive dystrophin gene transfer into skeletal muscle of adult mdx mice using a helper-dependent adenovirus vector expressing the coxsackievirus and adenovirus receptor (CAR) and dystrophin.
Uchida Y; Maeda Y; Kimura E; Yamashita S; Nishida Y; Arima T; Hirano T; Uyama E; Mita S; Uchino M
J Gene Med; 2005 Aug; 7(8):1010-22. PubMed ID: 15756716
[TBL] [Abstract][Full Text] [Related]
60. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
Koo T; Popplewell L; Athanasopoulos T; Dickson G
Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]